Dextroamphetamine Sustained-Release Capsules and Signifor
Determining the interaction of Dextroamphetamine Sustained-Release Capsules and Signifor and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextroamphetamine
Brand name: Dexedrine Spansule, ProCentra, Zenzedi, Dexedrine, Dextrostat, Liquadd
Synonyms: Dextroamphetamine
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextroamphetamine Sustained-Release Capsules-Signifor (Pasireotide Extended-Release Injection)
- Dextroamphetamine Sustained-Release Capsules-Signifor (Pasireotide Injection)
- Dextroamphetamine Sustained-Release Capsules-Signifor Injection
- Dextroamphetamine Sustained-Release Capsules-Signifor LAR
- Dextroamphetamine Sustained-Release Capsules-Signifor LAR Injection
- Dextroamphetamine Sustained-Release Capsules-Siklos
- Signifor-Dextroamphetamine Tablets
- Signifor-Dextromethorphan
- Signifor-Dextromethorphan and Chlorpheniramine Chewable Tablets
- Signifor-Dextromethorphan and Chlorpheniramine Liquid and Syrup
- Signifor-Dextromethorphan and Chlorpheniramine Tablets
- Signifor-Dextromethorphan and doxylamine